Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
High Prevalence and Clinical Correlates of Sarcopenia and Metabolic Syndrome in Outpatients with Major Depressive
Ching-I Hung1,2, Le-Yung Wang1,2, Huang-Li Lin1,2
1Department of Psychiatry, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
Objective:
This study aimed to investigate the percentages, clinical characteristics, and risk factors of sarcopenia and metabolic syndrome (MetS) among outpatients with major depressive disorder (MDD).
Methods:
This study enrolled 225 MDD outpatients based on DSM-V and age- and sex-matched health controls (HCs). Sarcopenia was diagnosed based on the 2019 Asian Working Group for Sarcopenia diagnostic criteria. Three psychometric scales and the Montreal Cognitive Assessment were used to evaluate the severities of depression, anxiety, and somatic symptoms and cognitive function, respectively. Binary logistic regression models were used to investigate the risk factors of the two disorders.
Results:
MDD subjects had significantly higher percentages of sarcopenia (41.3% vs 15.6%), MetS (40.9% vs 28.9%), and sarcopenia and/or MetS (68.9% vs 40.4%) than HCs. For elderly MDD subjects, 89.3% suffered from sarcopenia and/or MetS. MDD subjects had higher unqualified percentages in handgrip strength and three physical performance tests than HCs. MDD subjects with sarcopenia had worse depression than those without. MDD subjects with MetS had poorer cognitive function than those without. MDD subjects with only sarcopenia had worse mood symptoms than those with only MetS. After controlling for age and other variables, full remission of depression decreased the risk of sarcopenia. Being overweight decreased and increased the risk of sarcopenia and MetS, respectively.
Conclusions:
Most MDD outpatients, especially elderly outpatients, suffered from sarcopenia and/or MetS. The two disorders should be screened in MDD patients. Treatment of depression might decrease the risk of sarcopenia.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
13:35Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Psychological and Sociocultural Causes of Schizophrenia
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...